Ultomiris’ Shared “Now Approved” Page for Patients and HCPs




Brand: Ultomiris (ravulizumab-cwvz), Injection
Parent Company: Alexion Pharmaceuticals
Drug Type: Boxed Warning
Drug Category: Hematology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.ultomiris.com/
HCP Website: